Bionime Corp (4737)

Currency in TWD
55.70
+0.70(+1.27%)
Closed·
Advertisement
Earnings results expected tomorrow
4737 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.9055.80
52 wk Range
49.7573.03
Key Statistics
Bid/Ask
55.50 / 55.80
Prev. Close
55.7
Open
55
Day's Range
54.9-55.8
52 wk Range
49.75-73.03
Volume
46.35K
Average Volume (3m)
118.72K
1-Year Change
-18.2174%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4737 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Bionime Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
14/05/2026
EPS / Forecast
-1.09 / --
Revenue / Forecast
405.26M / --
EPS Revisions
Last 90 days

Compare 4737 to Peers and Sector

Metrics to compare
4737
Peers
Sector
Relationship
P/E Ratio
−17.2x23.2x−0.4x
PEG Ratio
0.220.200.00
Price/Book
1.9x2.3x2.6x
Price / LTM Sales
2.4x3.1x3.1x
Upside (Analyst Target)
-36.2%48.5%
Fair Value Upside
Unlock0.8%5.8%Unlock

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. The company also provides wholesale medical devices, biotechnology services, pharmaceutical testing, and wholesale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.

Employees
500
Market
Taiwan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
476.59K0.62%26.21M
Other Institutional Investors
22.75M29.43%1.25B
Public Companies & Retail Investors
54.06M69.95%2.97B
Total
77.29M100.00%4.25B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Tonghua Dongbao Pharmaceutical Co., Ltd.17.08%13,198,277725,905
Hua Eng Wire & Cable Co., Ltd.9.97%7,704,384423,741

FAQ

What Is the Bionime (Taiwan: 4737) Share Price Today?

The Bionime stock price today is 55.70 TWD.

What Stock Exchange Does Bionime (4737) Trade On?

Bionime is listed and trades on the Taiwan Stock Exchange.

What Is the Ticker (Stock Symbol) for Bionime?

The stock symbol (also called a 'ticker') for Bionime is "4737."

What Is the Current Bionime Market Capitalisation?

As of today, Bionime (Taiwan: 4737) market cap is 4.30B TWD.

What Is Bionime's (4737) Earnings Per Share (TTM)?

The Bionime EPS is currently -3.60 (Trailing Twelve Months).

When Is the Next Bionime Earnings Date?

Bionime's next earnings report will be released on 11/08/2026.

Is 4737 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bionime moving averages and other technical indicators, the daily buy/sell signal for 4737 stock is Strong Sell.

How Many Times Has Bionime Stock Split?

Bionime has split 3 times. (See the 4737 stock split history page for full effective split date and price information.)

How Many Employees Does Bionime Have?

Bionime has 500 employees, based on their latest Companies House report.

What is the current trading status of Bionime (Taiwan: 4737)?

As of 10/08/2026, Bionime (4737) is trading at a share price of 55.70 TWD, with a previous close of 55.70 TWD. The stock has fluctuated within a day range of 54.90 TWD to 55.80 TWD, while its 52-week range spans from 49.75 TWD to 73.03 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.